Liontrust Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Liontrust Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-112,559	Closed	-$4.91M	–	224
2023 Q1	$4.91M	Sell	112,559 -22,100	-16%	-$963K	0.07%	140
2022 Q4	$7.48M	Hold	134,659	–	–	0.13%	75
2022 Q3	$6.84M	Buy	+134,659	New	+$20M	0.11%	107

Other funds holding BHVN

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Liontrust Investment Partners's BHVN Position: Q2 2023 in Review

Liontrust Investment Partners sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2023, closing a stake of 112,559 shares — an estimated $4.91M sold.

Liontrust Investment Partners first reported a position in BHVN in Q3 2022 and held it in 3 quarters. The position peaked at $7.48M in Q4 2022. 1 fund tracked by Wall St. Rank holds BHVN as of Q2 2023.

Liontrust Investment Partners reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2023 after selling out during the quarter.
Liontrust Investment Partners sold 112,559 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2023, an estimated $4.91M.
Liontrust Investment Partners first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022 and held it in 3 quarters.
Liontrust Investment Partners's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7.48M in Q4 2022.
1 fund tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2023.

Based on Liontrust Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.